LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Denali Therapeutics (NASDAQ: DNLI)

Follow NASDAQ:DNLI Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ DNLI Denali Therapeutics
Schuth Alexander O. / officer: COFO and Secretary
08/12/2025
Sell
$13.58
2,937
$40K
242,346
NASDAQ DNLI Denali Therapeutics
Ho Carole / officer: Chief Medical Officer
08/12/2025
Sell
$13.58
2,937
$40K
217,391
NASDAQ DNLI Denali Therapeutics
Ho Carole / officer: Chief Medical Officer
08/13/2025
Sell
$14.64
806
$12K
216,585
NASDAQ DNLI Denali Therapeutics
Ho Carole / officer: Chief Medical Officer
08/05/2025
Buy
$0.68
44,655
$30K
220,328
NASDAQ DNLI Denali Therapeutics
Ho Carole / officer: Chief Medical Officer
08/05/2025
Sell
$0.68
44,655
$30K
62,500
NASDAQ DNLI Denali Therapeutics
Watts Ryan J. / director, officer: President and CEO
07/09/2025
Buy
$5.28
40,000
$211K
748,353
NASDAQ DNLI Denali Therapeutics
Watts Ryan J. / director, officer: President and CEO
07/09/2025
Buy
$0.68
455,282
$310K
708,353
NASDAQ DNLI Denali Therapeutics
Watts Ryan J. / director, officer: President and CEO
07/09/2025
Sell
$0.68
455,282
$310K
622,809
NASDAQ DNLI Denali Therapeutics
Watts Ryan J. / director, officer: President and CEO
07/09/2025
Sell
$15.00
495,282
$7.429M
253,071
NASDAQ DNLI Denali Therapeutics
Watts Ryan J. / director, officer: President and CEO
07/09/2025
Sell
$5.28
40,000
$211K
20,369

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous